Connection
Jamie Studts to Early Detection of Cancer
This is a "connection" page, showing publications Jamie Studts has written about Early Detection of Cancer.
|
|
Connection Strength |
|
 |
|
 |
|
5.544 |
|
|
|
-
Studts JL, Thurer RS, Studts CR, Byrne MM. Supporting community translation of lung cancer screening: A web-based decision aid to support informed decision making. Transl Behav Med. 2025 Jan 16; 15(1).
Score: 0.707
-
Hirsch EA, Hoover K, Studts JL. "They Need to Feel Non-Judgmental": Results of Participatory Photovoice Research to Inform Lung Cancer Screening Imagery. Cancer Control. 2024 Jan-Dec; 31:10732748241292567.
Score: 0.658
-
Studts JL, Hirsch EA, Silvestri GA. Shared Decision-Making During a Lung Cancer Screening Visit: Is It a Barrier or Does It Bring Value? Chest. 2023 01; 163(1):251-254.
Score: 0.597
-
Williams LB, Shelton BJ, Gomez ML, Al-Mrayat YD, Studts JL. Using Implementation Science to Disseminate a Lung Cancer Screening Education Intervention Through Community Health Workers. J Community Health. 2021 02; 46(1):165-173.
Score: 0.538
-
Eberth JM, Ersek JL, Terry LM, Bills SE, Chintanippu N, Carlos R, Hughes DR, Studts JL. Leveraging the Mammography Setting to Raise Awareness and Facilitate Referral to Lung Cancer Screening: A Qualitative Analysis. J Am Coll Radiol. 2020 Jul; 17(7):960-969.
Score: 0.504
-
Byrne MM, Thurer RJ, Studts JL. Individual decision making about lung cancer screening: A conjoint analysis of perspectives among a high-risk national sample. Cancer Med. 2019 09; 8(12):5779-5786.
Score: 0.485
-
Ruberg JL, Helm CW, Felleman BI, Helm JE, Studts JL. Is attendance at an ovarian cancer screening clinic a worry-reducing event? Findings from pre- to post-screening. Gynecol Oncol. 2017 Feb; 144(2):363-368.
Score: 0.404
-
Hirsch EA, Studts JL, Zane S, McCreight M, Huebschmann AG. Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool. J Am Board Fam Med. 2025 May 12; 38(1):56-83.
Score: 0.181
-
Wood DE, Kazerooni EA, Aberle DR, Argento C, Baines J, Boer B, Brown LM, Donington J, Eapen GA, Ferguson JS, Hou L, Klippenstein D, Kolansky AS, Kumar R, Leard LE, Leung ANC, Mazzone P, Merritt RE, Norris K, Onaitis M, Pipavath S, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Sears CR, Studts JL, Tanoue L, Thacker AL, Tong BC, Travis WD, Wei B, Westover K, McCullough B, Ramakrishnan S. NCCN Guidelines? Insights: Lung Cancer Screening, Version 1.2025. J Natl Compr Canc Netw. 2025 Jan; 23(1).
Score: 0.176
-
Lewis JA, Klein DE, Eberth JM, Carter-Bawa L, Studts JL, Tong BC, Smith RA, Kazerooni EA, Houston TP. The American Cancer Society National Lung Cancer Roundtable strategic plan: Provider engagement and outreach. Cancer. 2024 Dec 01; 130(23):3973-3984.
Score: 0.173
-
Crossnohere NL, Campoamor NB, Negash R, Wood M, Studts JL, Elsaid MI, Donneyong M, Paskett ED, Jonas DE, Stover DG, Doubeni CA, Bridges JFP. Public Perspectives on Multi-Cancer Early Detection: A Qualitative Study. Cancer Control. 2024 Jan-Dec; 31:10732748241291609.
Score: 0.165
-
Bilenduke E, Anderson S, Brenner A, Currier J, Eberth JM, King J, Land SR, Risendal BC, Shannon J, Siegel LN, Wangen M, Waters AR, Zahnd WE, Studts JL. Equitable implementation of lung cancer screening: avoiding its potential to mirror existing inequities among people who use tobacco. Cancer Causes Control. 2023 Dec; 34(Suppl 1):209-216.
Score: 0.161
-
Gomes R, Nederveld A, Glasgow RE, Studts JL, Holtrop JS. Lung cancer screening in rural primary care practices in Colorado: time for a more team-based approach? BMC Prim Care. 2023 03 03; 24(1):62.
Score: 0.155
-
Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, Ettinger DS, Ferguson JS, Hou L, Kadaria D, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Mazzone P, Merritt RE, Midthun DE, Onaitis M, Pipavath S, Pratt C, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Studts JL, Tanoue L, Tong BC, Travis WD, Wei B, Westover K, Yang SC, McCullough B, Hughes M. NCCN Guidelines? Insights: Lung Cancer Screening, Version 1.2022. J Natl Compr Canc Netw. 2022 07; 20(7):754-764.
Score: 0.148
-
Fedewa SA, Kazerooni EA, Studts JL, Smith RA, Bandi P, Sauer AG, Cotter M, Sineshaw HM, Jemal A, Silvestri GA. State Variation in Low-Dose?Computed Tomography Scanning for Lung Cancer Screening in the United States. J Natl Cancer Inst. 2021 08 02; 113(8):1044-1052.
Score: 0.139
-
Hirsch EA, Bar?n AE, Risendal B, Studts JL, New ML, Malkoski SP. Determinants Associated With Longitudinal Adherence to Annual Lung Cancer Screening: A Retrospective Analysis of Claims Data. J Am Coll Radiol. 2021 Aug; 18(8):1084-1094.
Score: 0.136
-
Zgodic A, Zahnd WE, Miller DP, Studts JL, Eberth JM. Predictors of Lung Cancer Screening Utilization in a Population-Based Survey. J Am Coll Radiol. 2020 Dec; 17(12):1591-1601.
Score: 0.129
-
Kiviniemi MT, Hay JL, James AS, Lipkus IM, Meissner HI, Stefanek M, Studts JL, Bridges JF, Close DR, Erwin DO, Jones RM, Kaiser K, Kash KM, Kelly KM, Craddock Lee SJ, Purnell JQ, Siminoff LA, Vadaparampil ST, Wang C. Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. Cancer Epidemiol Biomarkers Prev. 2009 Nov; 18(11):3133-7.
Score: 0.062
-
Cardarelli R, Reese D, Roper KL, Cardarelli K, Feltner FJ, Studts JL, Knight JR, Armstrong D, Weaver A, Shaffer D. Terminate lung cancer (TLC) study-A mixed-methods population approach to increase lung cancer screening awareness and low-dose computed tomography in Eastern Kentucky. Cancer Epidemiol. 2017 02; 46:1-8.
Score: 0.025
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|